Cargando…

The Reversal of Direct Oral Anticoagulants in Animal Models

Several direct oral anticoagulants (DOACs), including direct thrombin and factor Xa inhibitors, have been approved as alternatives to vitamin K antagonist anticoagulants. As with any anticoagulant, DOAC use carries a risk of bleeding. In patients with major bleeding or needing urgent surgery, revers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honickel, Markus, Akman, Necib, Grottke, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499974/ https://www.ncbi.nlm.nih.gov/pubmed/28471371 http://dx.doi.org/10.1097/SHK.0000000000000848

Ejemplares similares

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

Prothrombin complex concentrate restores haemostasis in a dabigatran anticoagulated polytrauma pig model
por: Honickel, M, et al.
Publicado: (2014)

The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination
por: Glund, Stephan, et al.
Publicado: (2018)

Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model
por: Honickel, M, et al.
Publicado: (2015)

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019)

The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old
por: Prexl, Oliver, et al.
Publicado: (2018)

Sufficient Thrombin Generation Despite 95% Hemodilution: An In Vitro Experimental Study
por: Gratz, Johannes, et al.
Publicado: (2020)

Reversal Strategies for Intracranial Hemorrhage Related to Direct Oral Anticoagulant Medications
por: Dabi, Alok, et al.
Publicado: (2018)

Pharmacological reversal of the direct oral anticoagulants—A comprehensive review of the literature
por: Shaw, Joseph R., et al.
Publicado: (2018)

Reversal of direct oral anticoagulants in hemophilia treatment: ASH meeting 2015
por: Feistritzer, Clemens, et al.
Publicado: (2016)

Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
por: Grottke, Oliver, et al.
Publicado: (2016)

Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model
por: Grottke, Oliver, et al.
Publicado: (2014)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution
por: Grottke, Oliver, et al.
Publicado: (2019)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
por: Shah, Shagun B, et al.
Publicado: (2019)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

In a trauma experimental pig model prothrombin complex concentrates and a specific antidote (idarucizumab) are effective to reverse the anticoagulant effects of dabigatran
por: Grottke, O, et al.
Publicado: (2014)

Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
por: Pfeilschifter, Waltraud, et al.
Publicado: (2022)

Direct oral anticoagulants and venous thromboembolism
por: Franchini, Massimo, et al.
Publicado: (2016)

Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry
por: Lindhoff-Last, Edelgard, et al.
Publicado: (2021)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals
por: Kanjee, Zahir, et al.
Publicado: (2021)

Direct oral anticoagulant: Review article
por: Nasiri, Abdulrahman, et al.
Publicado: (2022)

Reversal of oral anticoagulation in patients with acute intracerebral hemorrhage
por: Kuramatsu, Joji B., et al.
Publicado: (2019)

Pharmacokinetics of Phenprocoumon in Emergency Situations–Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry)
por: Lindhoff-Last, Edelgard, et al.
Publicado: (2022)

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
por: Hu, Tiffany Y, et al.
Publicado: (2016)

Perioperative management of patients on direct oral anticoagulants
por: Dubois, Virginie, et al.
Publicado: (2017)

Direct oral anticoagulants: integration into clinical practice
por: Cowell, Richard P W
Publicado: (2014)

Inherited Thrombophilia in the Era of Direct Oral Anticoagulants
por: Khider, Lina, et al.
Publicado: (2022)

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021)

Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
por: Mujer, Mark Terence P., et al.
Publicado: (2020)

Liver injury from direct oral anticoagulants
por: Juneja, Deven, et al.
Publicado: (2023)

Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants
por: Cullell, Natalia, et al.
Publicado: (2018)

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
por: Nakamura, Mashio, et al.
Publicado: (2017)

Evaluation of bleeding in patients receiving direct oral anticoagulants
por: Hellenbart, Erika L, et al.
Publicado: (2017)

Management of bleeding in patients treated with direct oral anticoagulants
por: Levi, Marcel
Publicado: (2016)

New Direct Oral Anticoagulants (DOAC) and Their Use Today
por: Schwarb, Heike, et al.
Publicado: (2016)

Pharmacogenetics of Direct Oral Anticoagulants: A Systematic Review
por: Raymond, Johanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5i4nk9j7po4724rk069mttmu7